EG23232A
(en )
2004-08-31
Absorbent article.
ZA200201806B
(en )
2003-05-28
Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
MXPA03001419A
(en )
2003-06-06
Therapeutic combination.
ZA200402688B
(en )
2005-02-08
Method and composition for preventing or reducing the symptons of insulin resistance syndrome.
AP2003002918A0
(en )
2003-12-31
Pulmonary administration of chemically modified insulin.
ZA200207650B
(en )
2004-03-23
Absorbent structure and absorbent articles containing the absorbent structure.
ZA200110173B
(en )
2002-09-25
Safety syringe.
BR0014930B1
(en )
2009-01-13
cannula.
MXPA02005950A
(en )
2003-10-14
Chair.
HK1051690A1
(en )
2003-08-15
Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
MXPA03009167A
(en )
2004-02-17
Absorbent product with improved fit.
EP1459776A4
(en )
2010-09-29
Syringe
MXPA03009204A
(en )
2004-01-29
Absorbent product with improved fit.
SG116454A1
(en )
2005-11-28
Absorbent article.
MXPA03006989A
(en )
2003-11-18
Modified leptin with reduced immunogenicity.
ZA200105690B
(en )
2002-09-25
Novel treatment.
PL370272A1
(en )
2005-05-16
Absorbent structure, and absorbent article containing the absorbent structure
MXPA03007625A
(en )
2003-12-04
Modified thrombopoietin with reduced immunogenicity.
ZA200301030B
(en )
2004-04-22
Treatment of the insulin resistance syndrome.
GB0024093D0
(en )
2000-11-15
Treatment of the insulin resistance syndrome
GB0030649D0
(en )
2001-01-31
Treatment of the insulin resistance syndrome
HK1056828A1
(en )
2004-03-05
Treatment of burns.
GB0128651D0
(en )
2002-01-23
Syringe
MXPA03008402A
(en )
2004-01-29
Modified insulin with reduced immunogenicity.
GB0106465D0
(en )
2001-05-02
Treatment of the insulin resistance syndrome